Evaluation of the effect of 6 months treatment with DC158AM on fatigue in patients with Parkinson's disease. Multicentre, randomised, double-blind, placebo-controlled study in parallel groups
Evaluation of the effect of 6 months treatment with DC158AM on fatigue in patients with Parkinson's disease. Multicentre, randomised, double-blind, placebo-controlled study in parallel groups
Evaluation of the effect of 6 months treatment with DC158AM on fatigue in patients with Parkinson's disease. Multicentre, randomised, double-blind, placebo-controlled study in parallel groups
Statut
Status :
Terminé
Type d'étude
Phase IV
Age Min.
45
Ans
Age Max.
80
Ans
Genre
Tous
Aire thérapeutique :
Santé mentale
Maladie :
Maladie de Parkinson
Traitement :
Debrumyl
Phase :
Phase IV
Date de début de l'étude :
07 Août 2008
End date :
02 Juillet 2010
Identifiant de l'essai :
DC0158 AM 401 1B
Identifiant EudraCT/CTIS :
2007-002195-34
Envoyer par email